Sulbactam/Ampicillin versus Cefotaxime as Initial Therapy in Serious Soft Tissue, Joint and Bone Infections

@article{Lffler2012SulbactamAmpicillinVC,
  title={Sulbactam/Ampicillin versus Cefotaxime as Initial Therapy in Serious Soft Tissue, Joint and Bone Infections},
  author={L. L{\"o}ffler and Adolf Bauernfeind and Werner Keyl},
  journal={Drugs},
  year={2012},
  volume={35},
  pages={46-52}
}
SummaryIn an open, randomised comparative study, 23 patients with bone, joint or soft tissue infections were treated with ampicillin 2g plus sulbactam 1g 3 times a day or cefotaxime 2g 3 times a day as an initial 2- week therapy. Monoinfections with Staphylococcus aureus were the most common bone or joint infections. Clinical cure or improvement 2 weeks after the end of therapy was observed in all 13 patients treated with sulbactam/ampicillin and in 7 of the 8 patients evaluated for efficacy… 
2 Citations
Ampicillin/Sulbactam
TLDR
Of particular interest during this era of increasing antimicrobial resistance in various settings and populations is the effectiveness of sulbactam against a considerable proportion of infections due to Acinetobacter baumannii.
Antibiotics for treating chronic osteomyelitis in adults.
TLDR
Limited and low quality evidence suggests that the route of antibiotic administration (oral versus parenteral) does not affect the rate of disease remission if the bacteria are susceptible to the antibiotic used.

References

SHOWING 1-9 OF 9 REFERENCES
An open, comparative study of sulbactam plus ampicillin vs. cefotaxime as initial therapy for serious soft tissue and bone and joint infections.
TLDR
The combination of sulbactam sodium plus ampicillin was at least equivalent to cefotaxime for the initial treatment of acute serious soft tissue and bone and joint infections.
Polymicrobial osteomyelitis: report of three cases and review of the literature.
TLDR
Polymicrobial osteomyelitis resulted most frequently from spread of infection from a contiguous focus or occurred in the patient with peripheral vascular insufficiency or neuropathy, however, the hematogenous route can produce polymicrobial disease.
Anaerobic osteomyelitis of long bones.
TLDR
The therapeutic necessity to remove all devitalized tissues, reestablish vascularity, graft bony defects, and combine this with long-term antibiotic therapy, preferably bactericidal against the causative organisms, is emphasized.
Diagnostic value of sinus-tract cultures in chronic osteomyelitis.
TLDR
A bacteriologic diagnosis of chronic osteomyelitis based on isolation of common pathogens other than S aureus from sinus tracts must be verified by an appropriate operative culture.
CP-45,899 in combination with penicillin or ampicillin against penicillin-resistant Staphylococcus, Haemophilus influenzae, and Bacteroides.
TLDR
Inhibitory concentrations of CP-45,899-ampicillin were bactericidal against H. influenzae strains and were as bactericidal as nafcillin or cephalothin against S. aureus.
In vitro efficacy of sulbactam combined with ampicillin against anaerobic bacteria
TLDR
The combination of sulbactam andAmpicillin was much more effective than ampicillin alone against Bacteroides fragilis strains but did not differ substantially from ampicisin alone against Fusobacterium spp.
CP-45,899, a Beta-Lactamase Inhibitor That Extends the Antibacterial Spectrum of Beta-Lactams: Initial Bacteriological Characterization
TLDR
CP-45,899 appears to be somewhat less potent but markedly more stable than the recently described β-lactamase inhibitor clavulanic acid and the spectrum extensions provided by the two compounds are similar.
Osteomyelitis: a review of clinical features, therapeutic considerations and unusual aspects.
Osteomyelitis Associated with Vascular Insufficiency The special problems connected with the presentation, clinical course, prognosis and treatment of osteomyelitis associated with vascular insuffi...
Diagnostic value of sinus
  • 1986